HBM HOLDINGS-B (02142): Chen Youchen appointed as Executive Director
Heptagon Pharmaceuticals-B (02142) announced that Dr. Rong Yiping has resigned as executive director for personal reasons, effective from August 27, 2026.
HBM HOLDINGS-B (02142) announced that Dr. Rong Yiping has resigned as Executive Director for personal reasons, effective August 27, 2026.
Following the recommendations of the Nomination Committee of the Board of Directors, Mr. Chen Youchen and Dr. Liu Yi have been appointed as Executive Directors, effective from the date of resignation.
After Dr. Rong's resignation, he will no longer serve as the authorized representative of the company under Rule 3.05 of the Listing Rules. Mr. Chen Youchen has been appointed as the authorized representative, effective from the date of resignation.
Related Articles

ZHONG JI LS (00767) released its interim results, reporting a loss attributable to shareholders of HKD 6.51 million, a year-on-year decrease of 48.21%.

JINYAN KAOLIN (02693) released its interim results, with a profit attributable to shareholders of 7.966 million yuan, a year-on-year decrease of 64.89%.

Suzhou Novosense Microelectronics (02676) released its interim results, with shareholders' profit attributable amounting to 67.591 million yuan, turning a profit compared to a loss in the same period last year.
ZHONG JI LS (00767) released its interim results, reporting a loss attributable to shareholders of HKD 6.51 million, a year-on-year decrease of 48.21%.

JINYAN KAOLIN (02693) released its interim results, with a profit attributable to shareholders of 7.966 million yuan, a year-on-year decrease of 64.89%.

Suzhou Novosense Microelectronics (02676) released its interim results, with shareholders' profit attributable amounting to 67.591 million yuan, turning a profit compared to a loss in the same period last year.

RECOMMEND





